Alta Partners — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

eGenesisegenesis.comFeb 2021

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

Board George M. Church(Director)

Co-investorsARCH Venture Partners Catalio Capital Management, LP HBM Healthcare Investments HBM Partners Khosla Ventures LifeSci Venture Partners +12 more

ROME Therapeuticsrometx.comSep 2021

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsAndreessen Horowitz ARCH Venture Partners GV (Google Ventures)Luma Group Sanofi Ventures Abingworth +11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.